The United States Patent and Trademark Office (USPTO) has granted patent US12582665B2 for a topical composition containing a cannabinoid. The patent abstract describes a solution comprising a cannabinoid, a polyhydric alcohol as a partition coefficient enhancer, a saturated long-chain fatty acid or alcohol (C10-C16) as a diffusion coefficient enhancer, and a co-solvent. This composition is intended for topical application and can be used in the treatment of various conditions.

This patent grant signifies new intellectual property protection for a specific pharmaceutical formulation. While not a regulatory rule, it may influence future product development and market entry for companies operating in the pharmaceutical and cannabis sectors. Compliance officers should note this development as it pertains to the landscape of cannabinoid-based therapeutics and potential patent infringement considerations.